Abstract
Clopidogrel resistance has been associated with increased periprocedural neurologic events after carotid artery stenting (CAS). Ticagrelor offers an improved resistance profile; however, its bleeding risk with CAS has not been assessed. We examined the safety and efficacy of perioperative dual antiplatelet therapy with aspirin (ASA) plus ticagrelor vs ASA plus clopidogrel in patients undergoing transfemoral CAS (TFCAS) or transcarotid artery revascularization (TCAR).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
